Glenmark Pharma to sell 7.84% stake in Glenmark Life Sciences via OFS - Moneycontrol

Glenmark Pharma to sell 7.84% stake in Glenmark Life Sciences via OFS - Moneycontrol
Inox India sets IPO price band at Rs 627-660, aims to raise Rs 1,459 crore from OFS - Moneycontrol
Ircon shares tank 8% as govt's OFS issue kicks off; stock up 166% YTD - Moneycontrol
SJVN crashes by 9% as government launches OFS to sell 2.46% equity at heavy discount - Moneycontrol
ONGC OFS likely to be launched today, govt to divest 5% stake - Moneycontrol
46.22MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US67103B1008
CUSIP
67103B100
Sector
Financial Services
Industry
Asset Management
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
1.83
Book Value
8.16
Dividend Share
1.02
Dividend Yield
29.57%
Earnings Share
-2.79
Wall Street Target Price
5.00
EPS Estimate Current Year
0.60
EPS Estimate Next Year
0.52
EPS Estimate Current Quarter
0.21
EPS Estimate Next Quarter
0.23
Most Recent Quarter
-
Revenue TTM
39,300,000
Gross Profit TTM
39,300,000
EBITDA
28,963,000
Profit Margin
-95.15%
Return On Assets TTM
4.76%
Return On Equity TTM
-27.73%
Revenue Per Share TTM
2.933
Qtly Revenue Growth YOY
-13.50%
Diluted Eps TTM
-2.79
Qtly Earnings Growth YOY
-6.30%
Trailing PE
0.00
Forward PE
9
Price Sales TTM
1.1216
Price Book MRQ
0.4228
Enterprise Value Revenue
34
Enterprise Value EBITDA
0
42.20
5.42%125.59
4.29%42.96
2.26%184.89
1.01%42.18
0.55%48.28
0.49%128.44
0.41%1089.00
-0.87%100.84
-0.17%545.60
-0.03%